Alvotech Overview
ALVO market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
ALVO price chart · 1M
- O
- 4.59
- H
- 4.91
- L
- 4.57
- C
- 4.87
- Vol
- 46,943.00
Daily history from Nov 18, 2020
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $4.59
- Previous Close
- $4.54
- Day High
- $4.91
- Day Low
- $4.57
- 52 Week High
- $6.53
- 52 Week Low
- $2.95
- 7 Day Return
- +4.74%
- 30 Day Return
- -16.98%
- 90 Day Return
- +28.70%
- 1 Year Return
- -3.85%
- Daily Notional Volume
- $228.4K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- 63.49 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.10 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -36.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.94 – $6.53 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.8B · P/S 3.58.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Alvotech kemur fram á fjórum fjárfestaráðstefnum í nóvemberGlobenewswire Inc ·
Alvotech to Present at Upcoming Investor Conferences in NovemberGlobenewswire Inc ·
Alvotech birtir uppgjör fyrstu níu mánaða ársins 2026 þann 11. nóvember nk.Globenewswire Inc ·